Thursday, April 15, 2021
Schwazze (SHWZ)
Call with Management
Medicine Man Technologies, Inc. is now operating under its new trade name, Schwazze. Schwazze is executing its strategy to become a leading vertically integrated cannabis holding company with a portfolio consisting of top-tier licensed brands spanning cultivation, extraction, infused-product manufacturing, dispensary operations, consulting, and a nutrient line. Schwazze leadership includes Colorado cannabis leaders with proven expertise in product and business development as well as top-tier executives from Fortune 500 companies. As a leading platform for vertical integration, Schwazze is strengthening the operational efficiency of the cannabis industry in Colorado and beyond, promoting sustainable growth and increased access to capital, while delivering best-quality service and products to the end consumer. The corporate entity continues to be named Medicine Man Technologies, Inc.
Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.
Refer to the full report for the price target, fundamental analysis, and rating.
Management Q&A. We recently had an opportunity to conduct a question and answer session with Schwazze CEO Justin Dye and CFO Nancy Huber. The call covered a wide range of topics including the current state of the business, the Star Buds acquisition, the state of the Colorado market, the M&A pipeline, and the legislative environment. We came away impressed with the Schwazze story and the opportunities available to the Company.
M&A Integration and Synergies. A key strength and differentiating factor of management, in our opinion, is bringing a “grocery store” mindset and operating model to the cannabis industry, which has much higher margins. Already, management has tripled Purplebees output and revenues and seen significant margin improvement in former Mesa retail dispensaries. This level of operating detail is being …
This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).
*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.
